Cellyan Biotechnology (HKPD) vs DataMeds AI (MEDS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
DataMeds AI is the larger company by market cap ($8.6 million vs $4.8 million), about 1.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HKPD | MEDS |
|---|---|---|
| Share price | $0.0971 | $3.04 |
| Market cap | $4.79M | $8.61M |
| 1-day change | -3.67% | -10.59% |
| EPS (TTM) | $-0.07 | $-46.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.72 | $73.00 |
| 52-week low | $0.095 | $0.823 |
| Distance from 52-week high | -94.35% | -95.84% |
| Average volume | 3.78M | 6.04M |
| Shares outstanding | 42.17M | 2.83M |
| Employees | 11 | — |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cellyan Biotechnology
HKPD stock →Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services.
Health Care · Other Pharmaceuticals · 11 employees
About DataMeds AI
MEDS stock →DataMEDS AI, Inc. operates as a health IT company in the United States.
Health Care · Other Pharmaceuticals
HKPD vs MEDS FAQ
Which is bigger, Cellyan Biotechnology or DataMeds AI?
DataMeds AI (MEDS) is larger, with a market capitalization of $8.61M compared with $4.79M for Cellyan Biotechnology (HKPD).
Are Cellyan Biotechnology and DataMeds AI in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.